Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
2.
Rev Esp Enferm Dig ; 104(9): 458-67, 2012 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-23130853

RESUMO

INTRODUCTION: endoscopic mucosal resection is an accepted technique for the treatment of proximal gastrointestinal tract superficial lesions. OBJECTIVES: to evaluate the efficacy and safety of this procedure in the proximal gastrointestinal tract. MATERIAL AND METHODS: forty one consecutive patients (23 males and 18 females, mean age of 61 ± 11.5 years) were included in our study. Fifty nine resections were performed in these patients in 69 sessions. Lesions treated consisted of elevated lesions with high grade dysplasia in the context of Barrett's esophagus (group A), high grade dysplasia appearing in random biopsies taken during the follow-up of Barrett's esophagus (group B) and superficial gastroduodenal lesions (group C). Snare resection after submucosal injection, band ligator-assisted or cap-assisted mucosal resection were the chosen techniques. RESULTS: we resected 7 elevated lesions with high grade dysplasia in the context of Barrett's esophagus, 6 complete Barrett's esophagus with high grade dysplasia in 16 sequential sessions and 46 gastroduodenal superficial lesions (10 adenomas, 9 gastric superficial carcinomas, 18 carcinoid tumours and 9 lesions of different histological nature). Resections in the two first groups were complete in 100% of the cases, and in 97.9% of the cases in group C. Complications included 2 cases of limited deferred bleeding (groups A and B) and another two cases of stenosis with little clinical relevance in Group B. CONCLUSIONS: a) endoscopic mucosal resection is an efficient technique for the treatment of proximal gastrointestinal tract superficial lesions; b) it is a safe procedure with a low percentage of complications, which can generally be managed endoscopically; and c) in contrast with other ablative techniques, endoscopic mucosal resection offers the possibility of a pathologic analysis of the samples.


Assuntos
Esôfago de Barrett/cirurgia , Duodenopatias/cirurgia , Duodenoscopia , Mucosa Gástrica/cirurgia , Gastroscopia , Mucosa Intestinal/cirurgia , Gastropatias/cirurgia , Adenocarcinoma/patologia , Adenocarcinoma/cirurgia , Adenoma/patologia , Adenoma/cirurgia , Adulto , Idoso , Idoso de 80 Anos ou mais , Esôfago de Barrett/patologia , Biópsia , Tumor Carcinoide/patologia , Tumor Carcinoide/cirurgia , Carcinoma in Situ/patologia , Carcinoma in Situ/cirurgia , Duodenopatias/patologia , Duodenoscopia/efeitos adversos , Eletrocoagulação/métodos , Feminino , Gastroscopia/efeitos adversos , Humanos , Leiomioma/patologia , Leiomioma/cirurgia , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Estudos Retrospectivos , Gastropatias/patologia , Neoplasias Gástricas/patologia , Neoplasias Gástricas/cirurgia
4.
Gastroenterol Hepatol ; 32(1): 2-8, 2009 Jan.
Artigo em Espanhol | MEDLINE | ID: mdl-19174093

RESUMO

INTRODUCTION: We analyzed the need to routinely perform a second gastroscopy after an initial diagnosis of benign gastric ulcer. METHOD: A total of 226 consecutive cases of gastric ulcer were reviewed. Sensitivity (S), specificity (Sp), positive and negative predictive value (PPV and NPV) and the accuracy of the initial gastroscopy plus biopsy were analyzed, both overall and according to the initial endoscopist's experience (attending or resident physician). The diagnostic accuracy of the initial and second-look gastroscopies was compared. The number of second endoscopies required to diagnose a new case of malignant gastric ulcer and their cost was calculated, both overall and according to the endoscopist's experience. RESULTS: There were 178 benign ulcers (79%) and 48 malignant ulcers (21%). The initial gastroscopy (S: 87.2%; Sp: 100%; PPV: 100%; PNV: 96.7%; accuracy: 96.7%) was performed by an attending physician in 74% of the patients and by a resident physician in the remaining 26%. Diagnostic accuracy was higher for attending physicians than for residents (98.2% vs. 94.8%; p=0.18). The accuracy of second-look endoscopy was 100%, with a significant improvement when compared with the initial procedure (p=0.035). Three new cases of MALT lymphoma and three new cases of gastric adenocarcinoma were diagnosed and could be treated with curative intent. The number of second gastroscopies required to diagnose a new case of malignant gastric ulcer and their economic cost was: 37.3 (4,675 Euros) for the whole group, 55.2 (6,845 Euros) for attending physicians and 19.3 (2,393 Euros) for residents. CONCLUSIONS: Initial gastroscopy showed high diagnostic accuracy, which was slightly lower when performed by resident physicians. Second-look gastroscopy significantly improved the results, confirming the clinical benefit of this procedure in diagnosing potentially curable malignant lesions. The mean cost of each new diagnosis of malignancy was 4,675 Euros, which was three times lower if the initial gastroscopy was performed by a less experienced endoscopist.


Assuntos
Gastroscopia , Neoplasias Gástricas/diagnóstico , Úlcera Gástrica/diagnóstico , Adenocarcinoma/diagnóstico , Adenocarcinoma/economia , Adenocarcinoma/patologia , Análise Custo-Benefício , Diagnóstico Diferencial , Diagnóstico Precoce , Mucosa Gástrica/patologia , Gastroscopia/economia , Gastroscopia/estatística & dados numéricos , Humanos , Internato e Residência , Linfoma de Zona Marginal Tipo Células B/diagnóstico , Linfoma de Zona Marginal Tipo Células B/economia , Linfoma de Zona Marginal Tipo Células B/patologia , Linfoma não Hodgkin/diagnóstico , Linfoma não Hodgkin/economia , Linfoma não Hodgkin/patologia , Corpo Clínico Hospitalar , Lesões Pré-Cancerosas/diagnóstico , Lesões Pré-Cancerosas/economia , Lesões Pré-Cancerosas/patologia , Valor Preditivo dos Testes , Reprodutibilidade dos Testes , Estudos Retrospectivos , Sensibilidade e Especificidade , Neoplasias Gástricas/economia , Neoplasias Gástricas/patologia , Úlcera Gástrica/economia , Úlcera Gástrica/patologia
5.
Prog. obstet. ginecol. (Ed. impr.) ; 60(2): 143-145, mar.-abr. 2017. tab
Artigo em Espanhol | IBECS (Espanha) | ID: ibc-164056

RESUMO

La infección por el virus de la hepatitis E es una causa clásica de hepatitis fulminante en la gestación que puede acarrear graves consecuencias materno-fetales. Las complicaciones fetales se derivan fundamentalmente de la transmisión vertical durante la gestación o el parto (hipotermia, hipoglucemia, hepatitis aguda, necrosis masiva hepática) y de un aumento de la prematuridad que conllevaría una mayor mortalidad neonatal. La peritonitis meconial se ha descrito como complicación de la infección materno-fetal por parvovirus B19, citomegalovirus, rubeola, virus de la hepatitis A y virus de la hepatitis B, sin que hayan sido comunicados en la bibliografía casos secundarios a la infección por virus de la hepatitis E. Presentamos el caso de una gestante de 19 semanas que ingresa por un cuadro de hepatitis aguda E, con diagnóstico fetal ecográfico prenatal compatible con peritonitis meconial (AU)


Hepatitis E virus infection is a classical cause of fulminant hepatitis during pregnancy, which can lead to severe maternal and fetal complications. Fetal complications are mainly derived from the vertical transmission during pregnancy or delivery (hypothermia, hypoglycaemia, acute hepatitis, massive liver necrosis) and from and increase in prematurity that would lead on to a greater neonatal mortality. Meconium peritonitis has been described as a complication of maternal and fetal infection by parvovirus B19, cytomegalovirus, rubella, hepatitis A virus and hepatitis B virus. There have been no published cases relating meconium peritonitis and hepatitis E virus infection. We present the case of a 19 week pregnant woman admitted with an acute hepatitis E, with a fetal prenatal ultrasound diagnosis of meconium peritonitis (AU)


Assuntos
Humanos , Feminino , Gravidez , Adulto , Peritonite/complicações , Peritonite/diagnóstico , Hepatite E/complicações , Complicações na Gravidez/fisiopatologia , Transmissão Vertical de Doenças Infecciosas , Hepatite E/transmissão , Parvovirus B19 Humano/isolamento & purificação , Parvovirus B19 Humano/patogenicidade , Leucocitose/complicações , Leucocitose/diagnóstico , Hiperbilirrubinemia/sangue , Diagnóstico Pré-Natal/métodos , Ascite/diagnóstico , Hiperbilirrubinemia/complicações
8.
Rev. esp. enferm. dig ; 104(9): 458-467, sept. 2012.
Artigo em Espanhol | IBECS (Espanha) | ID: ibc-107420

RESUMO

Introducción: la resección endoscópica mucosa es una técnica aceptada en el tratamiento de lesiones superficiales del tracto digestivo. Objetivos: evaluar la eficacia y seguridad de dicho procedimiento en el tracto digestivo superior. Material y métodos: se incluyeron en nuestro estudio 41 pacientes consecutivos (23 hombres y 18 mujeres, edad media de 60,6 años) a los que se les realizaron 59 resecciones en 69 sesiones. Se trataron las siguientes patologías: lesiones sobreelevadas con displasia de alto grado sobre esófago de Barrett (grupo A), displasia de alto grado en biopsias aleatorias del seguimiento de esófago de Barrett (grupo B) y lesiones superficiales gastroduodenales (grupo C). Las técnicas utilizadas fueron la resección con asa tras inyección submucosa, la asistida por bandas o por capuchón. Resultados: se resecaron 7 lesiones sobreelevadas con displasia de alto grado sobre esófago de Barrett, 6 esófagos de Barrett con displasia de alto grado de forma completa en 16 sesiones secuenciales de resección mucosa y 46 lesiones superficiales gastroduodenales (10 adenomas, 9 carcinomas gástricos superficiales, 18 carcinoides y 9 lesiones de diferente estirpe). Las resecciones se realizaron con éxito en el 100% de los dos primeros grupos y en el 97,9% del grupo C. Como complicaciones tuvimos 2 sangrados diferidos autolimitados (grupos A y B) y dos casos de estenosis con escasa relevancia clínica en el grupo B. Conclusiones: a) la resección endoscópica mucosa es una técnica eficaz en el tratamiento de lesiones superficiales del tracto digestivo superior; b) se trata de un procedimiento seguro, con un porcentaje de complicaciones muy bajo y que generalmente pueden ser manejadas de forma endoscópica; y c) al contrario que otras técnicas ablativas, permite el estudio anatomopatológico de las muestras(AU)


Introduction: endoscopic mucosal resection is an accepted technique for the treatment of proximal gastrointestinal tract superficial lesions. Objectives: to evaluate the efficacy and safety of this procedure in the proximal gastrointestinal tract. Material and methods: forty one consecutive patients (23 males and 18 females, mean age of 61 ± 11.5 years) were included in our study. Fifty nine resections were performed in these patients in 69 sessions. Lesions treated consisted of elevated lesions with high grade dysplasia in the context of Barrett’s esophagus (group A), high grade dysplasia appearing in random biopsies taken during the follow-up of Barrett’s esophagus (group B) and superficial gastroduodenal lesions (group C). Snare resection after submucosal injection, band ligator-assisted or cap-assisted mucosal resection were the chosen techniques. Results: we resected 7 elevated lesions with high grade dysplasia in the context of Barrett’s esophagus, 6 complete Barrett’s esophagus with high grade dysplasia in 16 sequential sessions and 46 gastroduodenal superficial lesions (10 adenomas, 9 gastric superficial carcinomas, 18 carcinoid tumours and 9 lesions of different histological nature). Resections in the two first groups were complete in 100% of the cases, and in 97.9% of the cases in group C. Complications included 2 cases of limited deferred bleeding (groups A and B) and another two cases of stenosis with little clinical relevance in Group B. Conclusions: a) endoscopic mucosal resection is an efficient technique for the treatment of proximal gastrointestinal tract superficial lesions; b) it is a safe procedure with a low percentage of complications, which can generally be managed endoscopically; and c) in contrast with other ablative techniques, endoscopic mucosal resection offers the possibility of a pathologic analysis of the samples(AU)


Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Idoso , Idoso de 80 Anos ou mais , Resultado do Tratamento , Avaliação de Eficácia-Efetividade de Intervenções , /métodos , /tendências , Esôfago de Barrett/complicações , Esôfago de Barrett/diagnóstico , Esôfago de Barrett/fisiopatologia , Esôfago de Barrett/cirurgia , Esôfago de Barrett , Estudos Retrospectivos , Estudos Prospectivos
9.
Gastroenterol. hepatol. (Ed. impr.) ; 32(1): 2-8, ene. 2009. ilus, tab, graf
Artigo em Espanhol | IBECS (Espanha) | ID: ibc-61362

RESUMO

Introducción: se discute la necesidad de efectuar sistemáticamente una segunda gastroscopia de control tras el diagnóstico inicial de una úlcera gástrica benigna. Método: revisamos 226 casos consecutivos de úlcera gástrica. Analizamos la sensibilidad (S), la especificidad (E), el valor predictivo positivo y negativo (VPP, VPN) y la precisión de la primera exploración: gastroscopia con biopsias, de modo global y según la experiencia del primer explorador (médico de plantilla o MIR). Comparamos la precisión diagnóstica entre la primera y la segunda endoscopia. Calculamos el número necesario de segundas exploraciones (NNE) para diagnosticar un nuevo caso de úlcera maligna y su coste, tanto global como según la experiencia del explorador. Resultados: registramos 178 (79%) úlceras benignas y 48 (21%) malignas. La primera exploración fue efectuada por un médico de plantilla (74%) y MIR (26%): S 87,2%, E 100%, VPP 100%, VPN 96,7% y precisión 96,7%. La precisión del médico de plantilla fue superior (98,2%) a la del MIR (94,8%) (p=0,18). La segunda exploración de control tuvo una precisión del 100%, mejorando significativamente a la primera (p=0,035) y diagnosticando 3 nuevos linfomas MALT y 3 carcinomas tratados con intención curativa. El NNE y el coste de un nuevo diagnóstico de lesión maligna fueron los siguientes: global, 37,3 (4.675 euros); médico de plantilla, 55,2 (6.845 euros), y MIR, 19,3 (2.393 euros). Conclusiones: la primera exploración obtuvo una elevada precisión diagnóstica, ligeramente menor para los MIR. La segunda endoscopia de control mejora significativamente los resultados, confirmando su beneficio clínico al diagnosticar lesiones malignas potencialmente curables. El coste medio de cada nuevo diagnóstico de malignidad ascendió a 4.675 euros, siendo 3 veces inferior si la primera exploración la efectúa un médico con menos experiencia(AU)


Introduction: We analyzed the need to routinely perform a second gastroscopy after an initial diagnosis of benign gastric ulcer. Method: A total of 226 consecutive cases of gastric ulcer were reviewed. Sensitivity (S), specificity (Sp), positive and negative predictive value (PPV and NPV) and the accuracy of the initial gastroscopy plus biopsy were analyzed, both overall and according to the initial endoscopist's experience (attending or resident physician). The diagnostic accuracy of the initial and second-look gastroscopies was compared. The number of second endoscopies required to diagnose a new case of malignant gastric ulcer and their cost was calculated, both overall and according to the endoscopist's experience. Results: There were 178 benign ulcers (79%) and 48 malignant ulcers (21%). The initial gastroscopy (S: 87.2%; Sp: 100%; PPV: 100%; PNV: 96.7%; accuracy: 96.7%) was performed by an attending physician in 74% of the patients and by a resident physician in the remaining 26%. Diagnostic accuracy was higher for attending physicians than for residents (98.2% vs. 94.8%; p=0.18). The accuracy of second-look endoscopy was 100%, with a significant improvement when compared with the initial procedure (p=0.035). Three new cases of MALT lymphoma and three new cases of gastric adenocarcinoma were diagnosed and could be treated with curative intent. The number of second gastroscopies required to diagnose a new case of malignant gastric ulcer and their economic cost was: 37.3 (4,675 Euros) for the whole group, 55.2 (6,845 Euros) for attending physicians and 19.3 (2,393 Euros) for residents(AU)


Conclusions: Initial gastroscopy showed high diagnostic accuracy, which was slightly lower when performed by resident physicians. Second-look gastroscopy significantly improved the results, confirming the clinical benefit of this procedure in diagnosing potentially curable malignant lesions. The mean cost of each new diagnosis of malignancy was 4,675 Euros, which was three times lower if the initial gastroscopy was performed by a less experienced endoscopist(AU)


Assuntos
Humanos , Úlcera Gástrica/diagnóstico , Gastroscopia/economia , Análise Custo-Benefício , Estudos Retrospectivos , Sensibilidade e Especificidade , Valor Preditivo dos Testes , Reprodutibilidade dos Testes , Lesões Pré-Cancerosas/diagnóstico , Diagnóstico Precoce
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa